Prospects in diagnosis and treatment of breast cancer : proceedings of the Joint International Symposium on Prospects in Diagnosis and Treatment of Breast Cancer, 10-11 November 1993, Munich, Germany
著者
書誌事項
Prospects in diagnosis and treatment of breast cancer : proceedings of the Joint International Symposium on Prospects in Diagnosis and Treatment of Breast Cancer, 10-11 November 1993, Munich, Germany
(International congress series, no. 1050)
Excerpta Medica, 1994
- : alk. paper
大学図書館所蔵 件 / 全6件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes index
内容説明・目次
内容説明
These papers are from a symposium which was organized with the following objectives: to bring together research-oriented clinicians and tumor biologists; to focus on mechanisms of factors of tumor biology with prognostic relevance; and to evaluate aspects of treatment oriented at tumor biology.
目次
- Part 1 Tumor cell proliferation, growth and differentiation: can oncogene and tumor suppressor genes aid in assessing node-negative mammary tumors?, H. Hofler et al
- new antibodies for the detection of the Ki-67 protein, M.H.G. Becker et al
- flow cytometric DNA analysis in primary breast cancer - technical pitfalls and clinical applications, N. Harbeck et al. Part 2 Tumor invasion and metastasis: structure and function of matrix metalloproteinases and their significance in breast cancer, H. Tschesche et al
- the role of cell adhesion molecules in metastasis formation by solid tumors, J.P. Johnson
- induction by urokinase-type plasminogen activator of c-fos gene expression in human ovarian cancer cells, I. Dumler et al. Part 3 Prognostic factors, new aspects of treatment: synthetic peptides for the inhibition of cell-cell and cell-matrix adhesion, R. Haubner et al
- reduction of metastatic tumor cells in bone marrow of breast cancer patients treated with monoclonal antibody, G. Schlimok et al
- integration of prognostic factors - can we predict breast cancer recurrences?, G.M. Clark and S.D. Hilsenbeck
- urokinase (uPA) and PAI-1 as selection criteria for adjuvant chemotherapy in axillary node-negative breast cancer patients, F. Janicke et al
- angiogenin is a valuable prognostic factor in node-negative breast cancer, J. Blaser et al. (Part Contents).
「Nielsen BookData」 より